lymphedema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 4.1 Women patients who have undergone unilateral breast cancer surgery. 4.2 Those who meet the diagnostic criteria for BCRL. 4.3 BCRL is staged as Grade 2 according to the ISL staging system. 4.4 Age >18 and <80 years old. 4.5 Voluntarily participating in this study, signing the informed consent form, and having the ability to comply with the treatment plan, examinations, and follow-up.
Exclusion criteria
Exclusion criteria: 5.1 Pregnant and/or breastfeeding women; 5.2 Individuals with infection, ulceration, or a tendency to bleed in the skin of the affected upper limb; 5.3 Patients with distant metastasis of breast cancer; 5.4 Patients currently undergoing breast cancer radiotherapy, chemotherapy, or targeted therapy; 5.5 Patients with severe heart, liver, lung, brain, or urinary system diseases, other malignant tumors, or other significant somatic diseases; 5.6 Patients with an expected survival period of less than 3 months; 5.7 Individuals prone to fainting or with allergic constitutions; 5.8 Patients with mental disorders, cognitive impairments, or unwillingness to cooperate; 5.9 Patients who have received other therapies (e.g., medications, CDT treatment, etc.) for upper limb lymphedema within the past month prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Circumference Difference Rate of Affected Side; | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin and subcutaneous tissue thickness;Skin and subcutaneous tissue hardness;Breast Cancer Lymphedema Symptom Index (BCLE-SEI) Scoring System;Upper Limb Function DASH Score Evaluation;Upper Limb Lymphedema Quality of Life (ULLQoL) Scale Scoring; | — |
Countries
China
Contacts
Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Integrated Chinese and Western Medicine Hospital